LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 770.25 2149 4086 0.5259 0.5315
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 770.25 2236 4086 0.5472 0.5569
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.73 770.25 2107 4086 0.5157 0.5190
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.95 770.25 2301 4543 0.5064 0.5333
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.95 770.25 2344 4543 0.5159 0.5444
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 38.95 770.25 2210 4543 0.4864 0.5093
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.17 770.25 2506 5010 0.5001 0.5476
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.17 770.25 2572 5010 0.5133 0.5625
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.17 770.25 2351 5010 0.4692 0.5114
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 43.39 770.25 2662 5404 0.4926 0.5546
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 43.39 770.25 2699 5404 0.4994 0.5622
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 43.39 770.25 2491 5404 0.4609 0.5183
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 45.61 770.25 2855 5813 0.4911 0.5672
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 45.61 770.25 2927 5813 0.5035 0.5807
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 45.61 770.25 2617 5813 0.4502 0.5211
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.83 770.25 3037 6223 0.4880 0.5764
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.83 770.25 3154 6223 0.5068 0.5963
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.83 770.25 2772 6223 0.4454 0.5294
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.05 770.25 3211 6629 0.4844 0.5836
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.05 770.25 3325 6629 0.5016 0.6015
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.05 770.25 3002 6629 0.4528 0.5497
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.27 770.25 3413 7058 0.4835 0.5933
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.27 770.25 3527 7058 0.4997 0.6097
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.27 770.25 3155 7058 0.4470 0.5545
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.49 770.25 3654 7555 0.4836 0.6042
MN20160304_L02
H19